[English] 日本語
Yorodumi
- PDB-5ngv: CRYSTAL STRUCTURE OF THE Activin receptor type-2B LIGAND BINDING ... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 5ngv
TitleCRYSTAL STRUCTURE OF THE Activin receptor type-2B LIGAND BINDING DOMAIN IN COMPLEX WITH BIMAGRUMAB FV, ORTHORHOMBIC CRYSTAL FORM
Components
  • Activin receptor type-2B
  • anti-human ActRIIB mAb BYM338 heavy-chain
  • anti-human ActRIIB mAb BYM338 light-chain
KeywordsTRANSFERASE / three-finger toxin fold / antibody Fv fragment
Function / homology
Function and homology information


Regulation of signaling by NODAL / activin receptor activity / lymphatic endothelial cell differentiation / positive regulation of activin receptor signaling pathway / venous blood vessel development / lymphangiogenesis / trophoblast cell migration / retina vasculature development in camera-type eye / embryonic foregut morphogenesis / activin receptor complex ...Regulation of signaling by NODAL / activin receptor activity / lymphatic endothelial cell differentiation / positive regulation of activin receptor signaling pathway / venous blood vessel development / lymphangiogenesis / trophoblast cell migration / retina vasculature development in camera-type eye / embryonic foregut morphogenesis / activin receptor complex / artery development / transforming growth factor beta receptor activity, type I / activin receptor activity, type I / activin receptor activity, type II / BMP receptor activity / receptor protein serine/threonine kinase / transforming growth factor beta receptor activity, type II / transforming growth factor beta receptor activity, type III / activin binding / pattern specification process / Signaling by BMP / Signaling by Activin / activin receptor signaling pathway / Signaling by NODAL / gastrulation with mouth forming second / pancreas development / kinase activator activity / determination of left/right symmetry / negative regulation of ossification / insulin secretion / negative regulation of cold-induced thermogenesis / anterior/posterior pattern specification / skeletal system morphogenesis / cell surface receptor protein serine/threonine kinase signaling pathway / organ growth / growth factor binding / mesoderm development / odontogenesis of dentin-containing tooth / roof of mouth development / blood vessel remodeling / BMP signaling pathway / positive regulation of bone mineralization / positive regulation of osteoblast differentiation / response to glucose / protein serine/threonine/tyrosine kinase activity / post-embryonic development / kidney development / lung development / cellular response to growth factor stimulus / heart development / intracellular iron ion homeostasis / receptor complex / protein serine/threonine kinase activity / regulation of DNA-templated transcription / negative regulation of transcription by RNA polymerase II / signal transduction / protein-containing complex / ATP binding / metal ion binding / plasma membrane / cytoplasm
Similarity search - Function
Activin types I and II receptor domain / Activin types I and II receptor domain / CD59 / CD59 / Ser/Thr protein kinase, TGFB receptor / Snake toxin-like superfamily / Ribbon / Serine/threonine-protein kinase, active site / Serine/Threonine protein kinases active-site signature. / Protein kinase domain ...Activin types I and II receptor domain / Activin types I and II receptor domain / CD59 / CD59 / Ser/Thr protein kinase, TGFB receptor / Snake toxin-like superfamily / Ribbon / Serine/threonine-protein kinase, active site / Serine/Threonine protein kinases active-site signature. / Protein kinase domain / Protein kinase domain profile. / Protein kinase domain / Immunoglobulins / Protein kinase-like domain superfamily / Immunoglobulin-like / Sandwich / Mainly Beta
Similarity search - Domain/homology
Activin receptor type-2B
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / molecular replacement / Resolution: 2 Å
Model detailsORTHORHOMBIC CRYSTAL FORM
AuthorsRondeau, J.-M. / Lehmann, S.
CitationJournal: Proc. Natl. Acad. Sci. U.S.A. / Year: 2017
Title: Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.
Authors: Morvan, F. / Rondeau, J.-M. / Zou, C. / Minetti, G. / Scheufler, C. / Scharenberg, M. / Jacobi, C. / Brebbia, P. / Ritter, V. / Toussaint, G. / Koelbing, C. / Leber, X. / Schilb, A. / Witte, ...Authors: Morvan, F. / Rondeau, J.-M. / Zou, C. / Minetti, G. / Scheufler, C. / Scharenberg, M. / Jacobi, C. / Brebbia, P. / Ritter, V. / Toussaint, G. / Koelbing, C. / Leber, X. / Schilb, A. / Witte, F. / Lehmann, S. / Koch, E. / Geisse, S. / Glass, D.J. / Lach-Trifilieff, E.
History
DepositionMar 20, 2017Deposition site: PDBE / Processing site: PDBE
Revision 1.0Nov 15, 2017Provider: repository / Type: Initial release
Revision 1.1Nov 29, 2017Group: Database references / Category: citation
Item: _citation.journal_volume / _citation.page_first / _citation.page_last
Revision 1.2Jan 31, 2018Group: Database references / Structure summary / Category: audit_author / citation_author / Item: _audit_author.name / _citation_author.name
Revision 2.0Mar 11, 2020Group: Polymer sequence / Category: entity_poly / Item: _entity_poly.pdbx_seq_one_letter_code_can
Revision 2.1Jan 17, 2024Group: Data collection / Database references / Refinement description
Category: chem_comp_atom / chem_comp_bond ...chem_comp_atom / chem_comp_bond / database_2 / pdbx_initial_refinement_model
Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession
Revision 2.2Oct 9, 2024Group: Structure summary / Category: pdbx_entry_details / pdbx_modification_feature

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Activin receptor type-2B
H: anti-human ActRIIB mAb BYM338 heavy-chain
L: anti-human ActRIIB mAb BYM338 light-chain
hetero molecules


Theoretical massNumber of molelcules
Total (without water)37,7454
Polymers37,5503
Non-polymers1941
Water3,135174
1


  • Idetical with deposited unit
  • defined by author&software
  • Evidence: gel filtration
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area4320 Å2
ΔGint-15 kcal/mol
Surface area14480 Å2
MethodPISA
Unit cell
Length a, b, c (Å)62.100, 114.170, 117.940
Angle α, β, γ (deg.)90.000, 90.000, 90.000
Int Tables number23
Space group name H-MI222
Components on special symmetry positions
IDModelComponents
11L-318-

HOH

-
Components

#1: Protein Activin receptor type-2B / Activin receptor type IIB / ACTR-IIB


Mass: 11646.901 Da / Num. of mol.: 1 / Fragment: LIGAND BINDING domain
Source method: isolated from a genetically manipulated source
Details: expressed as thioredoxin-His6-fusion protein with a PreScission cleavage site after the His-tag
Source: (gene. exp.) Homo sapiens (human) / Gene: ACVR2B / Production host: Escherichia coli (E. coli) / Variant (production host): Shuffle
References: UniProt: Q13705, receptor protein serine/threonine kinase
#2: Antibody anti-human ActRIIB mAb BYM338 heavy-chain


Mass: 13406.904 Da / Num. of mol.: 1 / Fragment: VH
Source method: isolated from a genetically manipulated source
Details: periplasmic expression / Source: (gene. exp.) Homo sapiens (human) / Production host: Escherichia coli (E. coli) / Variant (production host): W3110
#3: Antibody anti-human ActRIIB mAb BYM338 light-chain


Mass: 12496.670 Da / Num. of mol.: 1 / Fragment: VL
Source method: isolated from a genetically manipulated source
Details: periplasmic expression / Source: (gene. exp.) Homo sapiens (human) / Production host: Escherichia coli (E. coli) / Variant (production host): W3110
#4: Chemical ChemComp-PG4 / TETRAETHYLENE GLYCOL


Mass: 194.226 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: C8H18O5 / Comment: precipitant*YM
#5: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 174 / Source method: isolated from a natural source / Formula: H2O
Has protein modificationY

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.78 Å3/Da / Density % sol: 55.81 %
Crystal growTemperature: 293 K / Method: vapor diffusion / pH: 5.4 / Details: 0.1M PHOSPHATE-CITRATE, 40% PEG 300

-
Data collection

DiffractionMean temperature: 100 K
Diffraction sourceSource: SYNCHROTRON / Site: SLS / Beamline: X06DA / Wavelength: 1.00001 Å
DetectorType: MARMOSAIC 225 mm CCD / Detector: CCD / Date: Dec 14, 2009
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 1.00001 Å / Relative weight: 1
ReflectionResolution: 2→17.05 Å / Num. obs: 28674 / % possible obs: 99.8 % / Observed criterion σ(I): -3 / Redundancy: 4.439 % / Biso Wilson estimate: 33.4 Å2 / Rmerge F obs: 0.146 / Rmerge(I) obs: 0.07 / Rrim(I) all: 0.08 / Χ2: 0.956 / Net I/σ(I): 14.23 / Num. measured all: 127273 / Scaling rejects: 10
Reflection shell

Diffraction-ID: 1

Resolution (Å)Redundancy (%)Rmerge(I) obsMean I/σ(I) obsNum. unique obsRrim(I) all% possible all
2-2.054.3310.622.1820720.706100
2.05-2.114.4760.5232.6520360.59499.9
2.11-2.174.4950.443.2119940.49999.9
2.17-2.244.4630.3613.8919310.40999.8
2.24-2.314.5070.2824.9418890.3299.9
2.31-2.394.4830.2575.2918070.29199.9
2.39-2.484.4860.226.1717620.2599.9
2.48-2.584.50.1787.5716870.20199.9
2.58-2.74.5010.1399.4316260.15899.9
2.7-2.834.4640.10811.7315580.12399.8
2.83-2.984.4880.08514.8414540.09699.9
2.98-3.164.4570.06618.9714090.07599.9
3.16-3.384.4410.04924.2213300.05699.8
3.38-3.654.4710.03731.2312440.04399.8
3.65-44.3820.03334.9211300.03899.6
4-4.474.3970.03138.9610380.03599.5
4.47-5.164.3480.02941.339280.03399.3
5.16-6.324.3240.02938.557820.03399.2
6.32-8.944.1740.02839.426270.03299.7
8.94-17.053.7760.02442.363700.02998.4

-
Phasing

PhasingMethod: molecular replacement
Phasing MR
Highest resolutionLowest resolution
Rotation2.5 Å41.05 Å
Translation2.5 Å41.05 Å

-
Processing

Software
NameVersionClassification
XSCALEdata scaling
PHASER1.3.1phasing
BUSTER2.11.2refinement
PDB_EXTRACT3.22data extraction
XDSdata reduction
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: 2H64

2h64


Resolution: 2→17.05 Å / Cor.coef. Fo:Fc: 0.9368 / Cor.coef. Fo:Fc free: 0.9259 / SU R Cruickshank DPI: 0.136 / Cross valid method: THROUGHOUT / σ(F): 0 / SU R Blow DPI: 0.14 / SU Rfree Blow DPI: 0.122 / SU Rfree Cruickshank DPI: 0.121
RfactorNum. reflection% reflectionSelection details
Rfree0.1982 1431 5 %RANDOM
Rwork0.1768 ---
obs0.1779 28614 99.82 %-
Displacement parametersBiso max: 144.94 Å2 / Biso mean: 43.57 Å2 / Biso min: 22.35 Å2
Baniso -1Baniso -2Baniso -3
1-7.2596 Å20 Å20 Å2
2---15.272 Å20 Å2
3---8.0124 Å2
Refine analyzeLuzzati coordinate error obs: 0.224 Å
Refinement stepCycle: final / Resolution: 2→17.05 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms2469 0 13 174 2656
Biso mean--45.76 46.11 -
Num. residues----319
Refine LS restraints
Refine-IDTypeNumberRestraint functionWeightDev ideal
X-RAY DIFFRACTIONt_dihedral_angle_d854SINUSOIDAL2
X-RAY DIFFRACTIONt_trig_c_planes61HARMONIC2
X-RAY DIFFRACTIONt_gen_planes377HARMONIC5
X-RAY DIFFRACTIONt_it2555HARMONIC20
X-RAY DIFFRACTIONt_nbd
X-RAY DIFFRACTIONt_improper_torsion
X-RAY DIFFRACTIONt_pseud_angle
X-RAY DIFFRACTIONt_chiral_improper_torsion317SEMIHARMONIC5
X-RAY DIFFRACTIONt_sum_occupancies
X-RAY DIFFRACTIONt_utility_distance
X-RAY DIFFRACTIONt_utility_angle
X-RAY DIFFRACTIONt_utility_torsion
X-RAY DIFFRACTIONt_ideal_dist_contact2898SEMIHARMONIC4
X-RAY DIFFRACTIONt_bond_d2555HARMONIC20.01
X-RAY DIFFRACTIONt_angle_deg3465HARMONIC21.03
X-RAY DIFFRACTIONt_omega_torsion3.7
X-RAY DIFFRACTIONt_other_torsion17.55
LS refinement shellResolution: 2→2.08 Å / Rfactor Rfree error: 0 / Total num. of bins used: 14
RfactorNum. reflection% reflection
Rfree0.2238 147 4.99 %
Rwork0.2122 2799 -
all0.2128 2946 -
obs--99.82 %
Refinement TLS params.

Method: refined / Refine-ID: X-RAY DIFFRACTION

IDL11 (°2)L12 (°2)L13 (°2)L22 (°2)L23 (°2)L33 (°2)S11 (Å °)S12 (Å °)S13 (Å °)S21 (Å °)S22 (Å °)S23 (Å °)S31 (Å °)S32 (Å °)S33 (Å °)T11 (Å2)T12 (Å2)T13 (Å2)T22 (Å2)T23 (Å2)T33 (Å2)Origin x (Å)Origin y (Å)Origin z (Å)
13.74181.1340.48694.15041.04173.5502-0.1370.2233-0.4642-0.41310.4762-0.6070.14550.527-0.3392-0.0718-0.01410.0691-0.1344-0.1178-0.051611.83276.699718.3884
22.1670.913-0.1531.7276-0.0161.2748-0.06680.22080.1195-0.08360.11990.0004-0.09-0.0862-0.0531-0.07630.00730.0090.0260.0119-0.07868.870229.330824.2272
31.70640.06470.20220.84040.33662.3675-0.0021-0.2577-0.09680.04290.0055-0.07120.01750.0535-0.0034-0.07130.0026-0.00950.0360.0152-0.07942.527121.780243.7457
Refinement TLS group
IDRefine-IDRefine TLS-IDSelection detailsAuth asym-IDAuth seq-ID
1X-RAY DIFFRACTION1{ A|* }A25 - 117
2X-RAY DIFFRACTION2{ H|* }H1 - 114
3X-RAY DIFFRACTION3{ L|* }L1 - 112

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more